Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Late Extensive Regional Recurrence of Paratesticular Dedifferentiated Liposarcoma 10 Years after Orchiectomy: A Case Report

Дата публикации: 01-04-2026 12:10:40

Background: Paratesticular liposarcoma is a rare entity, with dedifferentiated liposarcoma (DDLPS) representing the most aggressive subtype. Late recurrences with unusual patterns of spread have been documented but remain poorly characterized.Case presentation: We report a case of a 68-year-old male with a 10-year recurrence of paratesticular DDLPS following right orchiectomy. The patient initially underwent resection of a 5×4×4.5 cm paratesticular mass in 2015, with histopathology confirming DDLPS and negative distal spermatic cord margins. After loss to follow-up, he presented in 2026 with extensive regional recurrence involving bilateral pubic soft tissues, abdominal wall musculature, and right external iliac lymphadenopathy. Biopsy confirmed recurrent DDLPS with Mouse double minute 2 homolog (MDM2) positivity. Given the multi-site infiltrative nature and muscle involvement, the multidisciplinary team recommended neoadjuvant chemotherapy with ifosfamide and doxorubicin before consideration of surgical resection.Conclusion: This case illustrates the propensity for late regional recurrence in paratesticular DDLPS and highlights the unusual pattern of spread along anatomic pathways, including the abdominal wall and inguinal region. The case underscores the importance of long-term surveillance, aggressive initial surgical margins, and multidisciplinary management in this rare malignancy.

Основное содержимое страницы с новостью.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Case Report: Giant Malignant Phyllodes Tumor of the Breast: Immediate Reconstruction with a Pedicled Latissimus Dorsi Myocutaneous Flap Following Total Mastectomy—A Case Report and Review of Reconstructive Considerations [version 2; peer review: 1 approved with reservations]07.708-08-2026
2Unveiling Disparities in WHO Grade II Glioma Care among Physicians in Middle East and North African (MENA) Countries: A Multidisciplinary Survey09.0130-01-2026
3Pathologic Response After Neoadjuvant Chemoimmunotherapy in Head and Neck Squamous Cell Carcinoma04.4413-08-2026
4Serum and Tumor PD-L1 Expression and Aggressive Clinicopathologic Features in Papillary Thyroid Carcinoma012.3713-08-2026
5Рак МЖ07.8712-08-2026
6Urinary Biomarkers: Is the Era of Exclusive Follow-Up Cystoscopy Coming to an End? A Mini-Review of Emerging Molecular Diagnostics and Risk-Stratified Surveillance08.0608-04-2026
7Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer014.2801-01-2025
8Ultrasensitive blood test predicts head and neck cancer relapse months earlier5710-06-2026
9Application of In vitro Reconstructed 3D Biomimetic Tumor Microenvironment Models in Cancer Research08.8208-06-2026
10Chugai Files for Additional Indication of Tecentriq for Adjuvant Treatment of MSI-High Colon Cancer013.4714-08-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.34. Источник: www.cancertherjournal.com.